-
1
-
-
0023505080
-
Polypeptide growth factors: Roles in normal and abnormal cell growth
-
Deuel, T. F. (1987) Polypeptide growth factors: roles in normal and abnormal cell growth. Annu. Rev. Cell Biol. 3, 443-492
-
(1987)
Annu. Rev. Cell Biol.
, vol.3
, pp. 443-492
-
-
Deuel, T.F.1
-
2
-
-
0022457822
-
The biology of platelet-derived growth factor
-
Ross, R., Raines, E. W. and Bowen-Pope, D. F. (1986) The biology of platelet-derived growth factor. Cell 46, 155-169 (Pubitemid 16031684)
-
(1986)
Cell
, vol.46
, Issue.2
, pp. 155-169
-
-
Ross, R.1
Raines, E.W.2
Bowen-Pope, D.F.3
-
3
-
-
0032462002
-
Evidence for distinct signaling properties and biological responses induced by the PDGF receptor α and β subtypes
-
Rosenkranz, S. and Kazlauskas, A. (1999) Evidence for distinct signaling properties and biological responses induced by the PDGF receptor α and β subtypes. Growth Factors 16, 201-216 (Pubitemid 129725725)
-
(1999)
Growth Factors
, vol.16
, Issue.3
, pp. 201-216
-
-
Rosenkranz, S.1
Kazlauskas, A.2
-
4
-
-
58249095931
-
Paracrine signaling by platelet-derived growth factor-CC promotes tumor growth by recruitment of cancer-associated fibroblasts
-
Anderberg, C., Li, H., Fredriksson, L., Andrae, J., Betsholtz, C., Li, X., Eriksson, U. and Pietras, K. (2009) Paracrine signaling by platelet-derived growth factor-CC promotes tumor growth by recruitment of cancer-associated fibroblasts. Cancer Res. 69, 369-378
-
(2009)
Cancer Res.
, vol.69
, pp. 369-378
-
-
Anderberg, C.1
Li, H.2
Fredriksson, L.3
Andrae, J.4
Betsholtz, C.5
Li, X.6
Eriksson, U.7
Pietras, K.8
-
5
-
-
57849106330
-
PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment
-
Crawford, Y., Kasman, I., Yu, L., Zhong, C., Wu, X., Modrusan, Z., Kaminker, J. and Ferrara, N. (2009) PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. Cancer Cell 15, 21-34
-
(2009)
Cancer Cell
, vol.15
, pp. 21-34
-
-
Crawford, Y.1
Kasman, I.2
Yu, L.3
Zhong, C.4
Wu, X.5
Modrusan, Z.6
Kaminker, J.7
Ferrara, N.8
-
6
-
-
0029039982
-
Expression of plateletderived growth factor B-chain and the platelet-derived growth factor receptor β subunit in human breast tissue and breast carcinoma
-
Coltrera, M. D., Wang, J., Porter, P. L. and Gown, A. M. (1995) Expression of plateletderived growth factor B-chain and the platelet-derived growth factor receptor β subunit in human breast tissue and breast carcinoma. Cancer Res. 55, 2703-2708
-
(1995)
Cancer Res.
, vol.55
, pp. 2703-2708
-
-
Coltrera, M.D.1
Wang, J.2
Porter, P.L.3
Gown, A.M.4
-
7
-
-
33644873490
-
Overexpression of platelet-derived growth factor receptor α in breast cancer is associated with tumour progression
-
Carvalho, I., Milanezi, F., Martins, A., Reis, R. M. and Schmitt, F. (2005) Overexpression of platelet-derived growth factor receptor α in breast cancer is associated with tumour progression. Breast Cancer Res. 7, R788-R795
-
(2005)
Breast Cancer Res.
, vol.7
-
-
Carvalho, I.1
Milanezi, F.2
Martins, A.3
Reis, R.M.4
Schmitt, F.5
-
8
-
-
0035032263
-
The complexities of breast cancer desmoplasia
-
Walker, R. A. (2001) The complexities of breast cancer desmoplasia. Breast Cancer Res. 3, 143-145
-
(2001)
Breast Cancer Res.
, vol.3
, pp. 143-145
-
-
Walker, R.A.1
-
9
-
-
0034618408
-
Human breast carcinoma desmoplasia is PDGF initiated
-
Shao, Z. M., Nguyen, M. and Barsky, S. H. (2000) Human breast carcinoma desmoplasia is PDGF initiated. Oncogene 19, 4337-4345
-
(2000)
Oncogene
, vol.19
, pp. 4337-4345
-
-
Shao, Z.M.1
Nguyen, M.2
Barsky, S.H.3
-
10
-
-
33745192635
-
Autocrine PDGFR signaling promotes mammary cancer metastasis
-
Jechlinger, M., Sommer, A., Moriggl, R., Seither, P., Kraut, N., Capodiecci, P., Donovan, M., Cordon-Cardo, C., Beug, H. and Grunert, S. (2006) Autocrine PDGFR signaling promotes mammary cancer metastasis. J. Clin. Invest. 116, 1561-1570
-
(2006)
J. Clin. Invest.
, vol.116
, pp. 1561-1570
-
-
Jechlinger, M.1
Sommer, A.2
Moriggl, R.3
Seither, P.4
Kraut, N.5
Capodiecci, P.6
Donovan, M.7
Cordon-Cardo, C.8
Beug, H.9
Grunert, S.10
-
11
-
-
0035242001
-
PDGC-C is an EWS/FLI induced transforming growth factor in Ewing family tumors
-
DOI 10.1038/sj.onc.1204133
-
Zwerner, J. P. and May, W. A. (2001) PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors. Oncogene 20, 626-633 (Pubitemid 32156187)
-
(2001)
Oncogene
, vol.20
, Issue.5
, pp. 626-633
-
-
Zwerner, J.P.1
May, W.A.2
-
12
-
-
0037198637
-
Dominant negative PDGF-C inhibits growth of Ewing family tumor cell lines
-
DOI 10.1038/sj/onc/1205486
-
Zwerner, J. P. and May, W. A. (2002) Dominant negative PDGF-C inhibits growth of Ewing family tumor cell lines. Oncogene 21, 3847-3854 (Pubitemid 34620852)
-
(2002)
Oncogene
, vol.21
, Issue.24
, pp. 3847-3854
-
-
Zwerner, J.P.1
May, W.A.2
-
13
-
-
0036645057
-
Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: Evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors
-
Lokker, N. A., Sullivan, C. M., Hollenbach, S. J., Israel, M. A. and Giese, N. A. (2002) Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. Cancer Res. 62, 3729-3735 (Pubitemid 34728854)
-
(2002)
Cancer Research
, vol.62
, Issue.13
, pp. 3729-3735
-
-
Lokker, N.A.1
Sullivan, C.M.2
Hollenbach, S.J.3
Israel, M.A.4
Giese, N.A.5
-
14
-
-
0036385854
-
Platelet-derived growth factor-B and -C and active α-receptors in medulloblastoma cells
-
Andrae, J., Molander, C., Smits, A., Funa, K. and Nister, M. (2002) Platelet-derived growth factor-B and -C and active α-receptors in medulloblastoma cells. Biochem. Biophys. Res. Commun. 296, 604-611
-
(2002)
Biochem. Biophys. Res. Commun.
, vol.296
, pp. 604-611
-
-
Andrae, J.1
Molander, C.2
Smits, A.3
Funa, K.4
Nister, M.5
-
15
-
-
0033776193
-
PDGF-C is a new protease-activated ligand for the PDGF α-receptor
-
Li, X., Ponten, A., Aase, K., Karlsson, L., Abramsson, A., Uutela, M., Backstrom, G., Hellstrom, M., Bostrom, H., Li, H. et al. (2000) PDGF-C is a new protease-activated ligand for the PDGF α-receptor. Nat. Cell Biol. 2, 302-309
-
(2000)
Nat. Cell Biol.
, vol.2
, pp. 302-309
-
-
Li, X.1
Ponten, A.2
Aase, K.3
Karlsson, L.4
Abramsson, A.5
Uutela, M.6
Backstrom, G.7
Hellstrom, M.8
Bostrom, H.9
Li, H.10
-
16
-
-
0035003785
-
PDGF-D is a specific, protease-activated ligand for the PDGF β-receptor
-
DOI 10.1038/35074588
-
Bergsten, E., Uutela, M., Li, X., Pietras, K., Ostman, A., Heldin, C. H., Alitalo, K. and Eriksson, U. (2001) PDGF-D is a specific, protease-activated ligand for the PDGF β-receptor. Nat. Cell Biol. 3, 512-516 (Pubitemid 32422089)
-
(2001)
Nature Cell Biology
, vol.3
, Issue.5
, pp. 512-516
-
-
Bergsten, E.1
Uutela, M.2
Li, X.3
Pietras, K.4
Ostman, A.5
Heldin, C.-H.6
Alitalo, K.7
Eriksson, U.8
-
17
-
-
0035920172
-
Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF α and β receptor
-
Gilbertson, D. G., Duff, M. E., West, J. W., Kelly, J. D., Sheppard, P. O., Hofstrand, P. D., Gao, Z., Shoemaker, K., Bukowski, T. R., Moore, M. et al. (2001) Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF α and β receptor. J. Biol. Chem. 276, 27406-27414
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 27406-27414
-
-
Gilbertson, D.G.1
Duff, M.E.2
West, J.W.3
Kelly, J.D.4
Sheppard, P.O.5
Hofstrand, P.D.6
Gao, Z.7
Shoemaker, K.8
Bukowski, T.R.9
Moore, M.10
-
18
-
-
22844439785
-
Structural requirements for activation of latent platelet-derived growth factor CC by tissue plasminogen activator
-
DOI 10.1074/jbc.M503388200
-
Fredriksson, L., Ehnman, M., Fieber, C. and Eriksson, U. (2005) Structural requirements for activation of latent platelet-derived growth factor CC by tissue plasminogen activator. J. Biol. Chem. 280, 26856-26862 (Pubitemid 41040719)
-
(2005)
Journal of Biological Chemistry
, vol.280
, Issue.29
, pp. 26856-26862
-
-
Fredriksson, L.1
Ehnman, M.2
Fieber, C.3
Eriksson, U.4
-
19
-
-
0023373687
-
Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes
-
Fuerst, T. R., Earl, P. L. and Moss, B. (1987) Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes. Mol. Cell. Biol. 7, 2538-2544
-
(1987)
Mol. Cell. Biol.
, vol.7
, pp. 2538-2544
-
-
Fuerst, T.R.1
Earl, P.L.2
Moss, B.3
-
20
-
-
6344236867
-
Tissue plasminogen activator is a potent activator of PDGF-CC
-
DOI 10.1038/sj.emboj.7600397
-
Fredriksson, L., Li, H., Fieber, C., Li, X. and Eriksson, U. (2004) Tissue plasminogen activator is a potent activator of PDGF-CC. EMBO J. 23, 3793-3802 (Pubitemid 39389710)
-
(2004)
EMBO Journal
, vol.23
, Issue.19
, pp. 3793-3802
-
-
Fredriksson, L.1
Li, H.2
Fieber, C.3
Li, X.4
Eriksson, U.5
-
21
-
-
39549100205
-
Plasmin is the major protease responsible for processing PDGF-C in the vitreous of patients with proliferative vitreoretinopathy
-
Lei, H., Velez, G., Hovland, P., Hirose, T. and Kazlauskas, A. (2008) Plasmin is the major protease responsible for processing PDGF-C in the vitreous of patients with proliferative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 49, 42-48
-
(2008)
Invest. Ophthalmol. Vis. Sci.
, vol.49
, pp. 42-48
-
-
Lei, H.1
Velez, G.2
Hovland, P.3
Hirose, T.4
Kazlauskas, A.5
-
22
-
-
33846965280
-
Streptokinase: The drug of choice for thrombolytic therapy
-
Kunamneni, A., Abdelghani, T. T. and Ellaiah, P. (2007) Streptokinase: the drug of choice for thrombolytic therapy. J. Thromb. Thrombolysis 23, 9-23
-
(2007)
J. Thromb. Thrombolysis
, vol.23
, pp. 9-23
-
-
Kunamneni, A.1
Abdelghani, T.T.2
Ellaiah, P.3
-
23
-
-
0034714379
-
Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates
-
Takeuchi, T., Harris, J. L., Huang, W., Yan, K. W., Coughlin, S. R. and Craik, C. S. (2000) Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J. Biol. Chem. 275, 26333-26342
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 26333-26342
-
-
Takeuchi, T.1
Harris, J.L.2
Huang, W.3
Yan, K.W.4
Coughlin, S.R.5
Craik, C.S.6
-
24
-
-
21744439110
-
Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells
-
DOI 10.1128/MCB.25.14.6279-6288.2005
-
Ustach, C. V. and Kim, H. R. (2005) Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells. Mol. Cell. Biol. 25, 6279-6288 (Pubitemid 40946575)
-
(2005)
Molecular and Cellular Biology
, vol.25
, Issue.14
, pp. 6279-6288
-
-
Ustach, C.V.1
Kim, H.-R.C.2
-
25
-
-
0026331304
-
Basic and clinical aspects of fibrinolysis and thrombolysis
-
Collen, D. and Lijnen, H. R. (1991) Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 78, 3114-3124
-
(1991)
Blood
, vol.78
, pp. 3114-3124
-
-
Collen, D.1
Lijnen, H.R.2
-
26
-
-
0029665065
-
The 2.3 Å crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator
-
Lamba, D., Bauer, M., Huber, R., Fischer, S., Rudolph, R., Kohnert, U. and Bode, W. (1996) The 2.3 Å crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator. J. Mol. Biol. 258, 117-135
-
(1996)
J. Mol. Biol.
, vol.258
, pp. 117-135
-
-
Lamba, D.1
Bauer, M.2
Huber, R.3
Fischer, S.4
Rudolph, R.5
Kohnert, U.6
Bode, W.7
-
27
-
-
0029645121
-
The crystal structure of the catalytic domain of human urokinase-type plasminogen activator
-
Spraggon, G., Phillips, C., Nowak, U. K., Ponting, C. P., Saunders, D., Dobson, C. M., Stuart, D. I. and Jones, E. Y. (1995) The crystal structure of the catalytic domain of human urokinase-type plasminogen activator. Structure 3, 681-691
-
(1995)
Structure
, vol.3
, pp. 681-691
-
-
Spraggon, G.1
Phillips, C.2
Nowak, U.K.3
Ponting, C.P.4
Saunders, D.5
Dobson, C.M.6
Stuart, D.I.7
Jones, E.Y.8
-
28
-
-
0036906177
-
uPAR: A versatile signalling orchestrator
-
DOI 10.1038/nrm977
-
Blasi, F. and Carmeliet, P. (2002) uPAR: a versatile signalling orchestrator. Nat. Rev. Mol. Cell Biol. 3, 932-943 (Pubitemid 35477371)
-
(2002)
Nature Reviews Molecular Cell Biology
, vol.3
, Issue.12
, pp. 932-943
-
-
Blasi, F.1
Carmeliet, P.2
-
29
-
-
0030064016
-
Distinct mechanisms contribute to stringent substrate specificity of tissue-type plasminogen activator
-
DOI 10.1074/jbc.271.8.4461
-
Coombs, G. S., Dang, A. T., Madison, E. L. and Corey, D. R. (1996) Distinct mechanisms contribute to stringent substrate specificity of tissue-type plasminogen activator. J. Biol. Chem. 271, 4461-4467 (Pubitemid 26070555)
-
(1996)
Journal of Biological Chemistry
, vol.271
, Issue.8
, pp. 4461-4467
-
-
Coombs, G.S.1
Dang, A.T.2
Madison, E.L.3
Corey, D.R.4
-
30
-
-
0030997660
-
Distinguishing the specificities of closely related proteases: Role of P3 in substrate and inhibitor discrimination between tissue-type plasminogen activator and urokinase
-
DOI 10.1074/jbc.272.26.16603
-
Ke, S. H., Coombs, G. S., Tachias, K., Navre, M., Corey, D. R. and Madison, E. L. (1997) Distinguishing the specificities of closely related proteases. Role of P3 in substrate and inhibitor discrimination between tissue-type plasminogen activator and urokinase. J. Biol. Chem. 272, 16603-16609 (Pubitemid 27276491)
-
(1997)
Journal of Biological Chemistry
, vol.272
, Issue.26
, pp. 16603-16609
-
-
Ke, S.-H.1
Coombs, G.S.2
Tachias, K.3
Navre, M.4
Corey, D.R.5
Madison, E.L.6
-
31
-
-
0030878999
-
Optimal subsite occupancy and design of a selective inhibitor of urokinase
-
DOI 10.1074/jbc.272.33.20456
-
Ke, S. H., Coombs, G. S., Tachias, K., Corey, D. R. and Madison, E. L. (1997) Optimal subsite occupancy and design of a selective inhibitor of urokinase. J. Biol. Chem. 272, 20456-20462 (Pubitemid 27355599)
-
(1997)
Journal of Biological Chemistry
, vol.272
, Issue.33
, pp. 20456-20462
-
-
Ke, S.-H.1
Coombs, G.S.2
Tachias, K.3
Corey, D.R.4
Madison, E.L.5
-
32
-
-
0025972053
-
Substrate specificity of tissue-type and urokinase-type plasminogen activators
-
Rijken, D. C. and Groeneveld, E. (1991) Substrate specificity of tissue-type and urokinase-type plasminogen activators. Biochem. Biophys. Res. Commun. 174, 432-438
-
(1991)
Biochem. Biophys. Res. Commun.
, vol.174
, pp. 432-438
-
-
Rijken, D.C.1
Groeneveld, E.2
-
33
-
-
0034608931
-
Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries
-
DOI 10.1073/pnas.140132697
-
Harris, J. L., Backes, B. J., Leonetti, F., Mahrus, S., Ellman, J. A. and Craik, C. S. (2000) Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries. Proc. Natl. Acad. Sci. U.S.A. 97, 7754-7759 (Pubitemid 30460720)
-
(2000)
Proceedings of the National Academy of Sciences of the United States of America
, vol.97
, Issue.14
, pp. 7754-7759
-
-
Harris, J.L.1
Backes, B.J.2
Leonetti, F.3
Mahrus, S.4
Ellman, J.A.5
Craik, C.S.6
-
34
-
-
0027474797
-
Identification and characterization of a novel matrix-degrading protease from hormone-dependent human breast cancer cells
-
Shi, Y. E., Torri, J., Yieh, L., Wellstein, A., Lippman, M. E. and Dickson, R. B. (1993) Identification and characterization of a novel matrix-degrading protease from hormone-dependent human breast cancer cells. Cancer Res. 53, 1409-1415 (Pubitemid 23097125)
-
(1993)
Cancer Research
, vol.53
, Issue.6
, pp. 1409-1415
-
-
Shi, Y.E.1
Torri, J.2
Yieh, L.3
Wellstein, A.4
Lippman, M.E.5
Dickson, R.B.6
-
35
-
-
0033603574
-
Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity
-
Lin, C. Y., Anders, J., Johnson, M., Sang, Q. A. and Dickson, R. B. (1999) Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity. J. Biol. Chem. 274, 18231-18236
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 18231-18236
-
-
Lin, C.Y.1
Anders, J.2
Johnson, M.3
Sang, Q.A.4
Dickson, R.B.5
-
36
-
-
0033613123
-
Reverse biochemistry: Use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue
-
DOI 10.1073/pnas.96.20.11054
-
Takeuchi, T., Shuman, M. A. and Craik, C. S. (1999) Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue. Proc. Natl. Acad. Sci. U.S.A. 96, 11054-11061 (Pubitemid 29487326)
-
(1999)
Proceedings of the National Academy of Sciences of the United States of America
, vol.96
, Issue.20
, pp. 11054-11061
-
-
Takeuchi, T.1
Shuman, M.A.2
Craik, C.S.3
-
37
-
-
0032923230
-
Cloning and chromosomal mapping of a gene isolated from thymic stromal cells encoding a new mouse type II membrane serine protease, epithin, containing four LDL receptor modules and two CUB domains
-
DOI 10.1007/s002510050515
-
Kim, M. G., Chen, C., Lyu, M. S., Cho, E. G., Park, D., Kozak, C. and Schwartz, R. H. (1999) Cloning and chromosomal mapping of a gene isolated from thymic stromal cells encoding a new mouse type II membrane serine protease, epithin, containing four LDL receptor modules and two CUB domains. Immunogenetics 49, 420-428 (Pubitemid 29178825)
-
(1999)
Immunogenetics
, vol.49
, Issue.5
, pp. 420-428
-
-
Kim, M.G.1
Chen, C.2
Lyu, M.S.3
Cho, E.-G.4
Park, D.5
Kozak, C.6
Schwartz, R.H.7
-
38
-
-
33646514271
-
Delineation of matriptase protein expression by enzymatic gene trapping suggests diverging roles in barrier function, hair formation, and squamous cell carcinogenesis
-
List, K., Szabo, R., Molinolo, A., Nielsen, B. S. and Bugge, T. H. (2006) Delineation of matriptase protein expression by enzymatic gene trapping suggests diverging roles in barrier function, hair formation, and squamous cell carcinogenesis. Am. J. Pathol. 168, 1513-1525
-
(2006)
Am. J. Pathol.
, vol.168
, pp. 1513-1525
-
-
List, K.1
Szabo, R.2
Molinolo, A.3
Nielsen, B.S.4
Bugge, T.H.5
-
39
-
-
0043246607
-
Characterization of matriptase expression in normal human tissues
-
Oberst, M. D., Singh, B., Ozdemirli, M., Dickson, R. B., Johnson, M. D. and Lin, C. Y. (2003) Characterization of matriptase expression in normal human tissues. J. Histochem. Cytochem. 51, 1017-1025 (Pubitemid 36919979)
-
(2003)
Journal of Histochemistry and Cytochemistry
, vol.51
, Issue.8
, pp. 1017-1025
-
-
Oberst, M.D.1
Singh, B.2
Ozdemirli, M.3
Dickson, R.B.4
Johnson, M.D.5
Lin, C.-Y.6
-
40
-
-
0035178571
-
Ovarian tumor cells express a transmembrane serine protease: A potential candidate for early diagnosis and therapeutic intervention
-
DOI 10.1159/000050604
-
Tanimoto, H., Underwood, L. J., Wang, Y., Shigemasa, K., Parmley, T. H. and O'Brien, T. J. (2001) Ovarian tumor cells express a transmembrane serine protease: a potential candidate for early diagnosis and therapeutic intervention. Tumour Biol. 22, 104-114 (Pubitemid 32008967)
-
(2001)
Tumor Biology
, vol.22
, Issue.2
, pp. 104-114
-
-
Tanimoto, H.1
Underwood, L.J.2
Wang, Y.3
Shigemasa, K.4
Parmley, T.H.5
O'Brien, T.J.6
-
41
-
-
0034711244
-
Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease
-
DOI 10.1074/jbc.M007802200
-
Lee, S. L., Dickson, R. B. and Lin, C. Y. (2000) Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J. Biol. Chem. 275, 36720-36725 (Pubitemid 32002078)
-
(2000)
Journal of Biological Chemistry
, vol.275
, Issue.47
, pp. 36720-36725
-
-
Lee, S.-L.1
Dickson, R.B.2
Lin, C.-Y.3
-
42
-
-
0035069846
-
Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo
-
Oberst, M., Anders, J., Xie, B., Singh, B., Ossandon, M., Johnson, M., Dickson, R. B. and Lin, C. Y. (2001) Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo. Am. J. Pathol. 158, 1301-1311 (Pubitemid 32281294)
-
(2001)
American Journal of Pathology
, vol.158
, Issue.4
, pp. 1301-1311
-
-
Oberst, M.1
Anders, J.2
Xie, B.3
Singh, B.4
Ossandon, M.5
Johnson, M.6
Dickson, R.B.7
Lin, C.-Y.8
-
43
-
-
22044445706
-
Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues
-
DOI 10.1038/sj.bjc.6602630
-
Riddick, A. C., Shukla, C. J., Pennington, C. J., Bass, R., Nuttall, R. K., Hogan, A., Sethia, K. K., Ellis, V., Collins, A. T., Maitland, N. J. et al. (2005) Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues. Br. J. Cancer 92, 2171-2180 (Pubitemid 40966253)
-
(2005)
British Journal of Cancer
, vol.92
, Issue.12
, pp. 2171-2180
-
-
Riddick, A.C.P.1
Shukla, C.J.2
Pennington, C.J.3
Bass, R.4
Nuttall, R.K.5
Hogan, A.6
Sethia, K.K.7
Ellis, V.8
Collins, A.T.9
Maitland, N.J.10
Ball, R.Y.11
Edwards, D.R.12
-
44
-
-
30644459109
-
Expression of serine protease SNC19/matriptase and its inhibitor hepatocyte growth factor activator inhibitr type 1 in normal and malignant tissues of gastrointestinal tract
-
Zeng, L., Cao, J. and Zhang, X. (2005) Expression of serine protease SNC19/matriptase and its inhibitor hepatocyte growth factor activator inhibitor type 1 in normal and malignant tissues of gastrointestinal tract. World J. Gastroenterol. 11, 6202-6207 (Pubitemid 43085066)
-
(2005)
World Journal of Gastroenterology
, vol.11
, Issue.39
, pp. 6202-6207
-
-
Zeng, L.1
Cao, J.2
Zhang, X.3
-
45
-
-
14844304649
-
Transmembrane serine protease TADG-15 (ST14/Matriptase/MT-SP1): Expression and prognostic value in ovarian cancer
-
DOI 10.1038/sj.bjc.6602320
-
Tanimoto, H., Shigemasa, K., Tian, X., Gu, L., Beard, J. B., Sawasaki, T. and O'Brien, T. J. (2005) Transmembrane serine protease TADG-15 (ST14/Matriptase/MT-SP1): expression and prognostic value in ovarian cancer. Br. J. Cancer 92, 278-283 (Pubitemid 40343141)
-
(2005)
British Journal of Cancer
, vol.92
, Issue.2
, pp. 278-283
-
-
Tanimoto, H.1
Shigemasa, K.2
Tian, X.3
Gu, L.4
Beard, J.B.5
Sawasaki, T.6
O'Brien, T.J.7
-
46
-
-
28344448867
-
Tissue-type plasminogen activator is upregulated in metastatic breast cancer cells exposed to insulin-like growth factor-I
-
Chernicky, C. L., Yi, L., Tan, H. and Ilan, J. (2005) Tissue-type plasminogen activator is upregulated in metastatic breast cancer cells exposed to insulin-like growth factor-I. Clin. Breast Cancer 6, 340-348 (Pubitemid 41715696)
-
(2005)
Clinical Breast Cancer
, vol.6
, Issue.4
, pp. 340-348
-
-
Chernicky, C.L.1
Yi, L.2
Tan, H.3
Ilan, J.4
-
47
-
-
18844373409
-
Tissue plasminogen activator expression in meningiomas and glioblastomas
-
DOI 10.1016/j.clineuro.2004.09.010, PII S0303846704001350
-
Goh, K. Y., Poon, W. S., Chan, D. T. and Ip, C. P. (2005) Tissue plasminogen activator expression in meningiomas and glioblastomas. Clin. Neurol. Neurosurg. 107, 296-300 (Pubitemid 40693505)
-
(2005)
Clinical Neurology and Neurosurgery
, vol.107
, Issue.4
, pp. 296-300
-
-
Goh, K.Y.C.1
Poon, W.S.2
Chan, D.T.M.3
Chui, P.I.4
-
48
-
-
33745305950
-
Identification of biomarkers of human pancreatic adenocarcinomas by expression profiling and validation with gene expression analysis in endoscopic ultrasound-guided fine needle aspiration samples
-
Laurell, H., Bouisson, M., Berthelemy, P., Rochaix, P., Dejean, S., Besse, P., Susini, C., Pradayrol, L., Vaysse, N. and Buscail, L. (2006) Identification of biomarkers of human pancreatic adenocarcinomas by expression profiling and validation with gene expression analysis in endoscopic ultrasound-guided fine needle aspiration samples. World J. Gastroenterol. 12, 3344-3351 (Pubitemid 43933778)
-
(2006)
World Journal of Gastroenterology
, vol.12
, Issue.21
, pp. 3344-3351
-
-
Laurell, H.1
Bouisson, M.2
Berthelemy, P.3
Rochaix, P.4
Dejean, S.5
Besse, P.6
Susini, C.7
Pradayrol, L.8
Vaysse, N.9
Buscail, L.10
-
49
-
-
33847671384
-
Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: Relation to prognosis and angiogenesis
-
DOI 10.1016/j.lungcan.2006.11.018, PII S0169500206006222
-
Offersen, B. V., Pfeiffer, P., Andreasen, P. and Overgaard, J. (2007) Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: relation to prognosis and angiogenesis. Lung Cancer 56, 43-50 (Pubitemid 46356642)
-
(2007)
Lung Cancer
, vol.56
, Issue.1
, pp. 43-50
-
-
Offersen, B.V.1
Pfeiffer, P.2
Andreasen, P.3
Overgaard, J.4
-
50
-
-
33847034860
-
Demethylation-linked activation of urokinase plasminogen activator is involved in progression of prostate cancer
-
Pulukuri, S. M., Estes, N., Patel, J. and Rao, J. S. (2007) Demethylation-linked activation of urokinase plasminogen activator is involved in progression of prostate cancer. Cancer Res. 67, 930-939
-
(2007)
Cancer Res.
, vol.67
, pp. 930-939
-
-
Pulukuri, S.M.1
Estes, N.2
Patel, J.3
Rao, J.S.4
-
51
-
-
0033946825
-
Urokinase plasminogen activator system gene expression is increased in human breast carcinoma and its bone metastases - A comparison of normal breast tissue, non-invasive carcinoma and osseous metastases
-
DOI 10.1023/A:1006445129195
-
Fisher, J. L., Field, C. L., Zhou, H., Harris, T. L., Henderson, M. A. and Choong, P. F. (2000) Urokinase plasminogen activator system gene expression is increased in human breast carcinoma and its bone metastases: a comparison of normal breast tissue, non-invasive and invasive carcinoma and osseous metastases. Breast Cancer Res. Treat. 61, 1-12 (Pubitemid 30440545)
-
(2000)
Breast Cancer Research and Treatment
, vol.61
, Issue.1
, pp. 1-12
-
-
Fisher, J.L.1
Field, C.L.2
Zhou, H.3
Harris, T.L.4
Henderson, M.A.5
Choong, P.F.M.6
-
52
-
-
0027361935
-
Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancers
-
Jankun, J., Merrick, H. W. and Goldblatt, P. J. (1993) Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancers. J. Cell. Biochem. 53, 135-144 (Pubitemid 23294599)
-
(1993)
Journal of Cellular Biochemistry
, vol.53
, Issue.2
, pp. 135-144
-
-
Jankun, J.1
Merrick, H.W.2
Goldblatt, P.J.3
-
53
-
-
20144386910
-
Tissue-Type plasminogen activator (tPA) in breast cancer: Relationship with clinicopathological parameters and prognostic significance
-
DOI 10.1007/s10549-004-2624-x
-
Corte, M. D., Verez, P., Rodriguez, J. C., Roibas, A., Dominguez, M. L., Lamelas, M. L., Vazquez, J., Garcia Muniz, J. L., Allende, M. T., Gonzalez, L. O. et al. (2005) Tissue-type plasminogen activator (tPA) in breast cancer: relationship with clinicopathological parameters and prognostic significance. Breast Cancer Res. Treat. 90, 33-40 (Pubitemid 40486999)
-
(2005)
Breast Cancer Research and Treatment
, vol.90
, Issue.1
, pp. 33-40
-
-
Corte, M.D.1
Verez, P.2
Rodriguez, J.C.3
Roibas, A.4
Dominguez, M.L.5
Lamelas, M.L.6
Vazquez, J.7
Garcia, M.J.L.8
Allende, M.T.9
Gonzalez, L.O.10
Fueyo, A.11
Vizoso, F.12
|